Madrigal Pharmaceuticals Inc’s recently made public that its Director FRIEDMAN PAUL A unloaded Company’s shares for reported $13.69 million on Dec 10 ’25. In the deal valued at $552.18 per share,24,800 shares were sold. As a result of this transaction, FRIEDMAN PAUL A now holds 187,164 shares worth roughly $104.44 million.
Then, Taub Rebecca sold 18,650 shares, generating $10,297,573 in total proceeds. Upon selling the shares at $552.15, the Director now owns 461,044 shares.
Before that, PAUL FRIEDMAN bought 49,600 shares. Madrigal Pharmaceuticals Inc shares valued at $27,474,432 were divested by the Director at a price of $553.92 per share.
Wolfe Research downgraded its Madrigal Pharmaceuticals Inc [MDGL] rating to a Peer perform from a an Outperform in a research note published on Tuesday. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who increased its forecast for the stock in early November from “a Neutral” to “an Overweight”. BofA Securities also remained covering MDGL and has increased its forecast on November 03, 2025 with a “Neutral” recommendation from previously “an Underperform” rating. Truist started covering the stock on October 15, 2025. It rated MDGL as “a Buy”.
Price Performance Review of MDGL
On Tuesday, Madrigal Pharmaceuticals Inc [NASDAQ:MDGL] saw its stock fall -5.16% to $558.01. On the same session, the stock had its day’s lowest price of $532.445, but rose to a high of $578.50. Over the last five days, the stock has lost -5.34%. Madrigal Pharmaceuticals Inc shares have risen nearly 77.83% since the year began. Nevertheless, the stocks have fallen -4.18% over the past one year. While a 52-week high of $615.00 was reached on 01/02/26, a 52-week low of $265.00 was recorded on 01/06/26.
Levels Of Support And Resistance For MDGL Stock
The 24-hour chart illustrates a support level at 534.14, which if violated will result in even more drops to 510.26. On the upside, there is a resistance level at 580.19. A further resistance level may holdings at 602.37.
How much short interest is there in Madrigal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Madrigal Pharmaceuticals Inc stocks on 2025-12-15, dropping by 67977.0 shares to a total of 3.72 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 3.79 million shares. There was a decline of -1.83%, which implies that there is a negative sentiment for the stock.
